« Return to News | Drug Sponsors

Valeant moves global headquarters to Quebec

Wednesday, April 4, 2012 01:48 PM

Valeant Pharmaceuticals International is moving its global headquarters to the Montreal region and establishing an R&D center of excellence for consumer dermatology in nearby Laval, Quebec.

With support from the Quebec government, Valeant hopes to set a precedent by becoming the first and only multinational pharmaceutical company to have its global headquarters in Quebec.

"Valeant has always had a strong Canadian presence and with our operations continuing to perform well, we expect to continue to increase our activities here in Canada," stated J. Michael Pearson, chairman and CEO, Valeant. 

In addition to having its head office in the Montreal region, Valeant will have other important assets in the province of Quebec, with Laboratoire Dr Renaud and a newly acquired manufacturing facility being critical components of the company's emerging position as a leader in the dermatology sector.

Pearson added, “The Montreal region [will be] a strategic development center for our consumer dermatology product division.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.